- Nail Changes During Docetaxel Containing Combination Chemotherapy
-
Woo IS, Shim KH, Kim GY, Lee MA, Kang JH, Hong YS, Lee KS
- KMID: 759702
- Korean J Intern Med.
- 2004 Jun;19(2):132-133.
Nail toxicity following systemic chemotherapy is common. Onychopathy during the period of neutropenia following chemotherapy may cause subungual abscesses and serious infection. Despite taxoid-related toxicity being increasingly reported since 2000,... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
-
Chung KH, Ryu JK, Son JH, Lee JW, Jang DK, Lee SH, Kim YT
- KMID: 2412198
- Gut Liver.
- 2017 Mar;11(2):298-305.
- doi: 10.5009/gnl16307
BACKGROUND/AIMS: Second-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma (PDAC) that progresses following gemcitabine-based treatment has not been established. This study aimed to investigate the efficacy and safety of... -
- CITED
-
- Close
- SHARE
-
- Close
- Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions
-
Maurer K, Michener C, Mahdi H, Rose PG
- KMID: 2413426
- J Gynecol Oncol.
- 2017 Jul;28(4):e38.
- doi: 10.3802/jgo.2017.28.e38
OBJECTIVE: To report on the incidence of nab-paclitaxel hypersensitivity reactions (HSRs) in patients with prior taxane HSR. METHODS: From 2005 to 2015, all patients who received nab-paclitaxel for a gynecologic malignancy... -
- CITED
-
- Close
- SHARE
-
- Close
- Systemic Chemotherapy in Advanced Pancreatic Cancer
-
Lee HS, Park SW
- KMID: 2411959
- Gut Liver.
- 2016 May;10(3):340-347.
- doi: 10.5009/gnl15465
Pancreatic cancer remains one of the most lethal cancers. These patients often have multiple symptoms, and integrated supportive care is critical in helping them remain well for as long as... -
- CITED
-
- Close
- SHARE
-
- Close
- Complete Remission of Unresectable Colon Cancer after Preoperative Chemotherapy Selected by Adenosine Triphosphate-Based Chemotherapy Response Assay
-
Huh JW, Park YA, Jung EJ, Lee KY, Kwon JE, Sohn SK
- KMID: 1783085
- J Korean Med Sci.
- 2008 Oct;23(5):916-919.
- doi: 10.3346/jkms.2008.23.5.916
The adenosine triphosphate-based chemotherapy response assay (ATP-CRA) is a chemosensitivity test that offers the potential of selecting cancer treatments based on the responsiveness of individual tumors. We report a case... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Outcome of Photodynamic Therapy with Systemic Chemotherapy Compared to Photodynamic Therapy Alone in Patients with Advanced Hilar Cholangiocarcinoma
-
Hong MJ, Cheon YK, Lee EJ, Lee TY, Shim CS
- KMID: 1774567
- Gut Liver.
- 2014 May;8(3):318-323.
BACKGROUND/AIMS: Patients with cholangiocarcinoma usually present at an advanced stage, and more than 50% of cases are not resectable at the time of diagnosis. Recently, photodynamic therapy (PDT) has been... -
- CITED
-
- Close
- SHARE
-
- Close
- Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma
-
Wentrup R, Winkelmann N, Mitroshkin A, Prager M, Voderholzer W, Schachschal G, Jürgensen C, Büning C
- KMID: 2411976
- Gut Liver.
- 2016 May;10(3):470-475.
- doi: 10.5009/gnl15175
BACKGROUND/AIMS: Standard treatments are not available for hilar nonresectable cholangiocarcinoma (NCC). It is unknown whether combination therapy of photodynamic therapy (PDT) plus systemic chemotherapy is superior to PDT alone. METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of Combination Chemotherapy with Gemcitabine, 5-fluorouracil, and Cisplatin for Advanced Pancreatic Cancer
-
Choi SB, Lee HY, Yuh YJ, Kim SR
- KMID: 772776
- Korean J Gastroenterol.
- 2005 May;45(5):348-353.
BACKGROUND/AIMS: Gemcitabine has been the standard regimen for advanced pancreatic cancer, but the effect on the response rate and survival is still disappointing, leading to many trials of combination... -
- CITED
-
- Close
- SHARE
-
- Close
- Gemcitabine, Etoposide, Cisplatin, and Dexamethasone in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
-
Kim KH, Joo YD, Sohn CH, Shin HJ, Chung JS, Cho GJ, Shin SH, Kim YS, Lee WS
- KMID: 1785640
- Korean J Intern Med.
- 2009 Mar;24(1):37-42.
- doi: 10.3904/kjim.2009.24.1.37
BACKGROUND/AIMS: To date, an effective salvage chemotherapy regimen for the treatment of refractory or relapsing non-Hodgkin's lymphoma (NHL) has not been discovered. This study was conducted to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
-
Moon DC, Lee HS, Lee YI, Chung MJ, Park JY, Park SW, Song SY, Chung JB, Bang S
- KMID: 2374156
- Yonsei Med J.
- 2016 Sep;57(5):1124-1130.
- doi: 10.3349/ymj.2016.57.5.1124
PURPOSE: Erlotinib-gemcitabine combined chemotherapy is considered as the standard treatment for unresectable pancreatic cancer. This study aimed to determine the clinical factors associated with response to this treatment. MATERIALS AND METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
